T1	Treatment 28 38	Tapentadol
T2	Treatment 71 114	Combination of Tapentadol PR and Pregabalin
T3	Treatment 302 315	tapentadol PR
T4	Treatment 335 359	tapentadol PR/pregabalin
T5	Treatment 602 611	baseline.
T6	Treatment 612 677	Patients were titrated to tapentadol PR 300 mg/day over 3 weeks
T7	Treatment 772 796	randomized to tapentadol
T8	Treatment 800 855	(500 mg/day) or tapentadol PR (300 mg/day)/pregabalin
T9	Treatment 963 979	effectiveness of
T10	Treatment 1013 1051	statistically comparable to tapentadol
T11	Treatment 1393 1407	of 500 mg/day
T12	Treatment 1626 1645	significantly lower
T13	Treatment 1651 1688	tapentadol PR (16.9%) than tapentadol
T14	Treatment 1711 1725	P = 0.0302).
T15	Treatment 1726 1737	CONCLUSIONS
T16	Treatment 1825 1849	quality-of-life measures
